Protein is an essential component of our diet. For the majority of people, a large portion of protein comes from meat. Yet, using animal as the machine to turn animal feeds into meat is a highly inefficient method. Conversion efficiency is only about 10%. It means that up to 90% of natural resources is wasted in the process and do not end up in the meats people consume. Compounded with the explosion of global population, our planet can no longer cope with the increasing demand.
In addition, this method has not been challenged nor changed since the primitive era. Change is imminent and it is important for our planet’s survival and our health.
Avant Meats is the first cultivated meat technology company in China with headquarters in Hong Kong. Our patent-pending technology enables businesses to produce meat without continuously catching or raising and killing animals. By removing the inefficient intermediary of an animal as the machine for delivering animal-based proteins, not only can we significantly improve the efficiency of the use of natural resources, we can also remove the undesirable and unintended elements that get into the process, such as pollutants and diseases.
We pilot with fish meat and marine proteins to address the problems of dwindling marine ecosystem, the gap between demand and supply of seafood and seafood safety issues.
According to A.T. Kearney’s research, the global meat market will grow to USD1.8 trillion by 2040. The market will be shared by cultivated meat (35%), plant-based meat (25%), and conventional meat (40%).
The production of cultivated meat makes use of stem cells, tissue engineering, and bioreactor technologies. Technical feasibility is, therefore, certain. What we need to do to commercialise is to reduce the production cost, remove all animal components from the process, and produce on a large scale.
We have achieved the first proof-of-concept prototype in Oct 2019. In Jun 2020, we have reached the key milestone of serum-free culture medium formulation. We will reach the pilot scale in and will start marketing our first product in 2021.
We pilot with fish for multiple reasons. 90% of the world’s marine fish stocks are now fully exploited, overexploited or depleted. Each year 2.7 trillion fish are caught from the wild and 37-120 billion fish are killed on commercial farms. Scientists predict that our oceans would be emptied by 2050.
Asia consumes over 60% of the world's seafood produce. China’s per capita consumption per year is over 40 kg, which is double the global average. China consumes 38% of global production.
Aquaculture appears to solve part of the supply problem. However, the number of species that are commercially farmed is limited. A lot of species cannot be domesticated and are still caught from the wild. Fish farms also create other environmental problems.
From the consumers’ perspective, there are multiple problems with the fish we eat now. Pollutants such as heavy metals, microplastics, and radioactive contamination have been found in fish caught from the sea. Antibiotics and parasites have been found in farmed fish.
The fish supply chain also has a large carbon footprint due to fuel used by vessels that need to go farther and farther to catch fish, air freight, and cold storage throughout the whole logistics. Fish farms also release a significant amount of methane.
The global fish meat market is estimated to reach USD 75 billion by 2024. Our primary focus is on China and Asia. Our products can be easily adapted for various applications for international markets.
Cell cultivation takes place in a clean and controlled environment. As such, we can guarantee our products are of 100% purity, higher & customisable nutritional value, source to product traceability, and species labelling accuracy.
Using our technology, we can produce fish meat and precious marine proteins without catching or raising fish anywhere in the world even for areas far from water.
Carrie is a seasoned business leader with a passion for the environment, particularly the impact of our food supply on the planet.
Her expertise ...
Read More
Dr Mario Chin
Chief Scientific Officer
Dr. Mario Chin has a wealth of experience in cutting-edge medical research and development. He is a bio-entrepreneur, successfully developed, comme...
Read More